USA and Europe different in aldosterone antagonists use in heart failure

A study published today, in JAMA (October 21) by Nancy M. Albert and colleagues, exploring aldosterone antagonist usage among US patients hospitalised with heart failure, found that only one-third of patients meeting current US Clinical Practice Guidelines criteria were actually being treated (1).

Read the whole article on Physorg

More from Physorg